The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults

Phase

N/A

Condition

Obesity

Diabetes And Hypertension

Diabetes Mellitus, Type 2

Treatment

Ceral Breakfast

powder shake with very low glycemic index

Clinical Study ID

NCT06856460

STUDY00016899

Ages 25-65
All Genders
Accepts Healthy Volunteers

Study Summary

Low glycemic index nutritional shakes have clinically shown to improve post-prandial glycemic responses in acute laboratory control studies. However, there is limited information on how replacing meals with low-glycemic index shake could impact glucose regulation in free-living adults consuming their own diets.

The present study aims to examine the impact of adding the SP Glucose-Assist shake to the breakfast of non-diabetic overweight and obese adults.

Subjects:

40 non-diabetic adults aged 25-65 years and body mass index ranging between 25-39 .

Protocol:

This is going to be a three-week study that will include a one-week self-selected diet, followed by two weeks of a breakfast supplement shake (standard process glucose assist) or control cereal oat breakfast.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Body mass index 25-40
Eating pattern 3 meals a day
stable weight for the last 2 months (<5 pounds fluctuation)
Willing to eat oat cereal for breakfast
glycated hemoglobin <7%

Exclusion

Exclusion Criteria:

glycated hemoglobin >7%
Body mass index ≤25 or ≥ 40
Night shifting work
Atypical meal pattern (not three meals a day or intermittent fasting)
Thyroid medication
Bariatric surgery
Habitual strenuous exercise
Commuting by bicycle
Eating disorders
Use of aspirin during the duration of the study
Intake of Vit C >60 mg/day during the study
cancer
cardiovascular disease
renal disease
hepatic disease
X-ray, MRI or CT appointment during the study duration
Current infection requiring medication
Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, orHIV
Medications of supplements that could affect body weight or appetite (i.e. Ozempic)
Participating in another study at the same time

Study Design